Revance Therapeutics Inc(RVNC)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

RVNC Revance Therapeutics Inc

交易中 05-09 10:44:24 EDT

4.35

+0.08

+1.87%

最高4.48	最低4.31	成交量16.62万
今开4.31	昨收4.27	日振幅3.98%
总市值4.53亿	流通市值3.63亿	总股本1.04亿
成交额72.54万	换手率0.20%	流通股本8,343万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"RVNC","market":"US","secType":"STK","nameCN":"Revance Therapeutics Inc","latestPrice":4.35,"timestamp":1715265844952,"preClose":4.27,"halted":0,"volume":166181,"delay":0,"floatShares":83429768,"shares":104215614,"eps":-3.829999,"marketStatus":"交易中","marketStatusCode":2,"change":0.08,"latestTime":"05-09 10:44:24 EDT","open":4.31,"high":4.475,"low":4.305,"amount":725387.6262355,"amplitude":0.039813,"askPrice":4.35,"askSize":120,"bidPrice":4.34,"bidSize":314,"shortable":3,"etf":0,"ttmEps":-3.829999,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1715284800000},"adr":0,"listingDate":1391662800000,"adjPreClose":4.27,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":4.27,"preClose":4.27,"latestTime":"08:00 EDT","volume":1,"amount":4.27,"timestamp":1715256000085},"postHourTrading":{"tag":"盘后","latestPrice":4.27,"preClose":4.27,"latestTime":"19:58 EDT","volume":52767,"amount":225308.47,"timestamp":1715212686377},"volumeRatio":0.690939},"requestUrl":"/m/hq/s/RVNC","defaultTab":"news","newsList":[{"id":"2433875785","title":"Revance Therapeutics Inc    预计每股亏损 75 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2433875785","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2433875785?lang=zh_cn&edition=full","pubTime":"2024-05-08 08:07","pubTimestamp":1715126843,"startTime":"0","endTime":"0","summary":"   * Revance Therapeutics Inc    将于5月9日发布截至2024年3月31日的季度业绩报告，预计该公司的季度收入将有所增长。* 根据LSEG的数据，7位分析师的平均预期显示，这家总部位于田纳西州纳什维尔的公司的营收有望从去年同期的4933万美元增长14.8%，达到5663.4万美元。* LSEG 分析师对 Revance Therapeutics Inc 的平均预期是每股亏损 75 美分。* 华尔街对 Revance Therapeutics Inc 的 12 个月目标价中位数为 12.00 美元，高于其上次收盘价 4.38 美元。5月8日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2433873568","title":"Revance Therapeutics, Inc.盘中异动 大幅上涨5.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2433873568","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2433873568?lang=zh_cn&edition=full","pubTime":"2024-05-08 02:07","pubTimestamp":1715105253,"startTime":"0","endTime":"0","summary":"北京时间2024年05月08日02时07分，Revance Therapeutics, Inc.股票出现波动，股价快速上涨5.61%。Revance Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.82%。其相关个股中，Revelation Biosciences Inc C/Wts 10/01/2027 、Lexaria Bioscience Corp C/Wts 14/01/2026 、Carmell Corp C/Wts 12/07/2028 涨幅较大，Clearmind Medicine Inc.、Allarity Therapeutics, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为1460.73%、263.66%、193.57%，振幅较大的相关个股有Revelation Biosciences Inc C/Wts 10/01/2027 、Psyence Biomedical Ltd C/Wts 25/01/2029、Avenue Therapeutics, Inc.，振幅分别为96.50%、56.63%、42.73%。Revance Therapeutics, Inc.公司简介：Revance Therapeutics Inc 是一家专注于美容和治疗产品的生物技术公司，包括其神经调节剂产品 DaxibotulinumtoxinA for Injection。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240508020734861eb867&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240508020734861eb867&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432236153","title":"Revance Therapeutics Inc    预计每股亏损 75 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2432236153","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2432236153?lang=zh_cn&edition=full","pubTime":"2024-05-04 06:15","pubTimestamp":1714774506,"startTime":"0","endTime":"0","summary":"   * Revance Therapeutics Inc    将于5月9日发布截至2024年3月31日的季度业绩报告，预计该公司的季度收入将有所增长。* 根据LSEG的数据，7位分析师的平均预期显示，这家总部位于田纳西州纳什维尔的公司的营收有望从去年同期的4933万美元增长14.8%，达到5663.4万美元。* LSEG 分析师对 Revance Therapeutics Inc 的平均预期是每股亏损 75 美分。* 华尔街对 Revance Therapeutics Inc 的 12 个月目标价中位数为 12.00 美元，高于其上次收盘价 3.95 美元。5月3日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2432970259","title":"Revance Therapeutics, Inc.盘中异动 大幅上涨5.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2432970259","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432970259?lang=zh_cn&edition=full","pubTime":"2024-05-03 21:30","pubTimestamp":1714743048,"startTime":"0","endTime":"0","summary":"北京时间2024年05月03日21时30分，Revance Therapeutics, Inc.股票出现异动，股价大幅拉升5.57%。Revance Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.06%。其相关个股中，Vaxxinity, Inc.、Ardelyx, Inc.、Jaguar Health, Inc.涨幅较大，Allarity Therapeutics, Inc.、Vaxxinity, Inc.、Jaguar Health, Inc.较为活跃，换手率分别为57.88%、20.98%、10.03%，振幅较大的相关个股有Relay Therapeutics, Inc.、Rani Therapeutics Holdings, Inc.、Zymeworks Inc.，振幅分别为13.56%、12.87%、6.37%。Revance Therapeutics, Inc.公司简介：Revance Therapeutics Inc 是一家专注于美容和治疗产品的生物技术公司，包括其神经调节剂产品 DaxibotulinumtoxinA for Injection。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240503213049861ead19&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240503213049861ead19&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431286758","title":"Revance Therapeutics, Inc.盘中异动 早盘急速拉升5.00%报3.57美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2431286758","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431286758?lang=zh_cn&edition=full","pubTime":"2024-04-29 22:13","pubTimestamp":1714400010,"startTime":"0","endTime":"0","summary":"北京时间2024年04月29日22时13分，Revance Therapeutics, Inc.股票出现异动，股价大幅拉升5.00%。Revance Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.01%。其相关个股中，Nkgen Biotech Inc C/Wts 31/05/2028、Soleno Therapeutics, Inc.、Genenta Science Spa涨幅较大，Zyversa Therapeutics, Inc.、Biodexa Pharmaceuticals Plc、Avenue Therapeutics, Inc.较为活跃，换手率分别为871.99%、33.52%、17.48%，振幅较大的相关个股有Cassava Sciences Inc C/Wts 15/11/2024、Zyversa Therapeutics, Inc.、Immunitybio, Inc.，振幅分别为33.33%、31.06%、29.01%。Revance Therapeutics, Inc.公司简介：Revance Therapeutics Inc 是一家专注于美容和治疗产品的生物技术公司，包括其神经调节剂产品 DaxibotulinumtoxinA for Injection。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240429221330861ea1b7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240429221330861ea1b7&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430501278","title":"艾伯维因 Skyrizi 销售强劲而上调年度利润预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2430501278","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2430501278?lang=zh_cn&edition=full","pubTime":"2024-04-26 19:36","pubTimestamp":1714131396,"startTime":"0","endTime":"0","summary":"艾伯维和其投资者一直关注较新的免疫学药物Skyrizi和Rinvoq的销售情况，以抵消Humira对销售额的侵蚀--Humira是全球销量最大的药物，直到去年它失去了独家代理权，并出现了近似的仿制药。Skyrizi 的销售额为 20.1 亿美元，超过了预期的 19.4 亿美元，而 Rinvoq 的销售额为 10.9 亿美元，略高于预期的 10.6 亿美元。本季度，Humira 的销售额下降了近 36%，为 22.7 亿美元，与预期的 22.8 亿美元基本一致。本季度Imbruvica的销售收入为8.38亿美元，高于预期的7.44亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2430289522","title":"Revance Therapeutics, Inc.盘中异动 股价大跌5.04%报3.39美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430289522","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430289522?lang=zh_cn&edition=full","pubTime":"2024-04-25 21:42","pubTimestamp":1714052536,"startTime":"0","endTime":"0","summary":"北京时间2024年04月25日21时42分，Revance Therapeutics, Inc.股票出现异动，股价大幅下挫5.04%。Revance Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.36%。其相关个股中，Processa Pharmaceuticals, Inc.、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Zura Bio Limited C/Wts 涨幅较大，Processa Pharmaceuticals, Inc.、Cyclacel Pharmaceuticals, Inc.、Cidara Therapeutics, Inc.较为活跃，换手率分别为1044.08%、188.15%、7.59%，振幅较大的相关个股有Cassava Sciences Inc C/Wts 15/11/2024、Processa Pharmaceuticals, Inc.、凯信远达，振幅分别为40.85%、25.31%、14.75%。Revance Therapeutics, Inc.公司简介：Revance Therapeutics Inc 是一家专注于美容和治疗产品的生物技术公司，包括其神经调节剂产品 DaxibotulinumtoxinA for Injection。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404252142167a55b446&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404252142167a55b446&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427873323","title":"Revance Therapeutics, Inc.盘中异动 股价大跌5.04%报3.77美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2427873323","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427873323?lang=zh_cn&edition=full","pubTime":"2024-04-16 21:48","pubTimestamp":1713275299,"startTime":"0","endTime":"0","summary":"北京时间2024年04月16日21时48分，Revance Therapeutics, Inc.股票出现波动，股价快速跳水5.04%。Revance Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.98%。其相关个股中，Jaguar Health, Inc.、Marinus Pharmaceuticals, Inc.、Lexaria Bioscience Corp C/Wts 14/01/2026 涨幅较大，Biorestorative Therapies, Inc.、Jaguar Health, Inc.、Soligenix, Inc.较为活跃，换手率分别为103.19%、42.30%、34.75%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Jaguar Health, Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025，振幅分别为101.56%、34.68%、32.06%。Revance Therapeutics, Inc.公司简介：Revance Therapeutics Inc 是一家专注于美容和治疗产品的生物技术公司，包括其神经调节剂产品 DaxibotulinumtoxinA for Injection。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240416214819861e6521&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240416214819861e6521&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426190468","title":"Revance Therapeutics, Inc.盘中异动 早盘快速拉升5.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426190468","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426190468?lang=zh_cn&edition=full","pubTime":"2024-04-09 21:57","pubTimestamp":1712671037,"startTime":"0","endTime":"0","summary":"北京时间2024年04月09日21时57分，Revance Therapeutics, Inc.股票出现异动，股价快速上涨5.28%。Revance Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.02%。其相关个股中，Acrivon Therapeutics, Inc.、Biophytis、Mymd Pharmaceuticals, Inc.涨幅较大，Mymd Pharmaceuticals, Inc.、Biophytis、Acrivon Therapeutics, Inc.较为活跃，换手率分别为376.21%、93.02%、47.81%，振幅较大的相关个股有Biophytis、Mymd Pharmaceuticals, Inc.、Cadrenal Therapeutics, Inc.，振幅分别为24.30%、22.18%、21.39%。Revance Therapeutics, Inc.公司简介：Revance Therapeutics Inc 是一家专注于美容和治疗产品的生物技术公司，包括其神经调节剂产品 DaxibotulinumtoxinA for Injection。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404092157187a51a6ae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404092157187a51a6ae&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424304682","title":"Revance Therapeutics, Inc.盘中异动 早盘急速下挫5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2424304682","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2424304682?lang=zh_cn&edition=full","pubTime":"2024-04-02 21:51","pubTimestamp":1712065895,"startTime":"0","endTime":"0","summary":"北京时间2024年04月02日21时51分，Revance Therapeutics, Inc.股票出现异动，股价大幅下跌5.06%。Revance Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.41%。其相关个股中，Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Sab Biotherapeutics Inc C/Wts 22/10/2026 、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 涨幅较大，Aditxt, Inc.、Avalo Therapeutics, Inc.、Ibio, Inc.较为活跃，换手率分别为655.04%、21.65%、15.32%，振幅较大的相关个股有Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Aditxt, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 ，振幅分别为95.84%、56.92%、41.53%。Revance Therapeutics, Inc.公司简介：Revance Therapeutics Inc 是一家专注于美容和治疗产品的生物技术公司，包括其神经调节剂产品 DaxibotulinumtoxinA for Injection。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040221513587e7da27&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040221513587e7da27&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422918907","title":"Revance Therapeutics, Inc.盘中异动 早盘股价大涨5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422918907","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422918907?lang=zh_cn&edition=full","pubTime":"2024-03-27 22:01","pubTimestamp":1711548082,"startTime":"0","endTime":"0","summary":"北京时间2024年03月27日22时01分，Revance Therapeutics, Inc.股票出现波动，股价急速上涨5.11%。Revance Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.24%。其相关个股中，Ibio, Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Lixte Biotechnology Holdings, Inc.涨幅较大，Ibio, Inc.、Lixte Biotechnology Holdings, Inc.、Hoth Therapeutics, Inc.较为活跃，换手率分别为1490.99%、882.34%、53.13%，振幅较大的相关个股有Ibio, Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Lixte Biotechnology Holdings, Inc.，振幅分别为60.00%、49.61%、45.23%。Revance Therapeutics, Inc.公司简介：Revance Therapeutics Inc 是一家专注于美容和治疗产品的生物技术公司，包括其神经调节剂产品 DaxibotulinumtoxinA for Injection。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240327220122861e1b10&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240327220122861e1b10&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422613664","title":"Revance Therapeutics, Inc.盘中异动 快速拉升5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422613664","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422613664?lang=zh_cn&edition=full","pubTime":"2024-03-26 21:32","pubTimestamp":1711459941,"startTime":"0","endTime":"0","summary":"北京时间2024年03月26日21时32分，Revance Therapeutics, Inc.股票出现异动，股价快速拉升5.16%。Revance Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.33%。其相关个股中，Stoke Therapeutics, Inc.、180 Life Sciences Corp C/Wts 07/11/2025、Abvc Biopharma, Inc.涨幅较大，Abvc Biopharma, Inc.、Xtl生物制药、Stoke Therapeutics, Inc.较为活跃，换手率分别为99.46%、11.05%、10.02%，振幅较大的相关个股有Stoke Therapeutics, Inc.、Molecular Templates, Inc.、Sellas Life Sciences Group, Inc.，振幅分别为24.77%、14.64%、9.62%。Revance Therapeutics, Inc.公司简介：Revance Therapeutics Inc 是一家专注于美容和治疗产品的生物技术公司，包括其神经调节剂产品 DaxibotulinumtoxinA for Injection。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403262132217a4f3428&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403262132217a4f3428&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422578504","title":"Revance Therapeutics, Inc.盘中异动 下午盘股价大跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422578504","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422578504?lang=zh_cn&edition=full","pubTime":"2024-03-26 03:29","pubTimestamp":1711394951,"startTime":"0","endTime":"0","summary":"北京时间2024年03月26日03时29分，Revance Therapeutics, Inc.股票出现异动，股价大幅跳水5.03%。Revance Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.16%。其相关个股中，Landos Biopharma, Inc.、Altamira Therapeutics Ltd.、Clene Inc C/Wts 30/12/2025 涨幅较大，Altamira Therapeutics Ltd.、Xtl生物制药、Salarius Pharmaceuticals, Inc.较为活跃，换手率分别为3358.82%、450.24%、80.09%，振幅较大的相关个股有Altamira Therapeutics Ltd.、Xtl生物制药、Zura Bio Limited，振幅分别为80.35%、78.61%、47.80%。Revance Therapeutics, Inc.公司简介：Revance Therapeutics Inc 是一家专注于美容和治疗产品的生物技术公司，包括其神经调节剂产品 DaxibotulinumtoxinA for Injection。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403260329117a4eedcd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403260329117a4eedcd&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421829716","title":"Revance Therapeutics, Inc.盘中异动 股价大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2421829716","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421829716?lang=zh_cn&edition=full","pubTime":"2024-03-23 03:17","pubTimestamp":1711135030,"startTime":"0","endTime":"0","summary":"北京时间2024年03月23日03时17分，Revance Therapeutics, Inc.股票出现波动，股价急速下挫5.01%。Revance Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.14%。其相关个股中，Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Moolec Science Sa C/Wts 、Virios Therapeutics, Inc.涨幅较大，Outlook Therapeutics, Inc.、Adial Pharmaceuticals, Inc、180 Life Sciences Corp.较为活跃，换手率分别为94.32%、54.59%、44.36%，振幅较大的相关个股有Virios Therapeutics, Inc.、Moolec Science Sa C/Wts 、Matinas Biopharma Holdings, Inc.，振幅分别为86.19%、75.83%、66.00%。Revance Therapeutics, Inc.公司简介：Revance Therapeutics Inc 是一家专注于美容和治疗产品的生物技术公司，包括其神经调节剂产品 DaxibotulinumtoxinA for Injection。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032303171187e7b1e3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032303171187e7b1e3&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421466740","title":"Revance Therapeutics, Inc.盘中异动 早盘股价大涨5.13%报5.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2421466740","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421466740?lang=zh_cn&edition=full","pubTime":"2024-03-21 21:39","pubTimestamp":1711028353,"startTime":"0","endTime":"0","summary":"北京时间2024年03月21日21时39分，Revance Therapeutics, Inc.股票出现波动，股价大幅拉升5.13%。截至发稿，该股报5.33美元/股，成交量5.8404万股，换手率0.06%，振幅4.34%。Revance Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.53%。Revance Therapeutics, Inc.公司简介：Revance Therapeutics Inc 是一家专注于美容和治疗产品的生物技术公司，包括其神经调节剂产品 DaxibotulinumtoxinA for Injection。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240321213913791c05fa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240321213913791c05fa&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420583403","title":"Revance Therapeutics, Inc.盘中异动 股价大跌5.00%报5.04美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2420583403","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420583403?lang=zh_cn&edition=full","pubTime":"2024-03-18 22:16","pubTimestamp":1710771408,"startTime":"0","endTime":"0","summary":"北京时间2024年03月18日22时16分，Revance Therapeutics, Inc.股票出现异动，股价急速下跌5.00%。Revance Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.22%。其相关个股中，180 Life Sciences Corp C/Wts 07/11/2025、Immuneering Corporation、Fresh2 Group Limited涨幅较大，Zyversa Therapeutics, Inc.、Immuneering Corporation、Scisparc Ltd.较为活跃，换手率分别为74.38%、22.00%、15.76%，振幅较大的相关个股有Immuneering Corporation、Tc Biopharm  Plc C/Wts 10/02/2028 、Conduit Pharmaceuticals Inc C/Wts 22/09/2028，振幅分别为67.02%、50.00%、36.75%。Revance Therapeutics, Inc.公司简介：Revance Therapeutics Inc 是一家专注于美容和治疗产品的生物技术公司，包括其神经调节剂产品 DaxibotulinumtoxinA for Injection。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403182216487a4d7105&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403182216487a4d7105&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419651598","title":"Revance Therapeutics, Inc.盘中异动 下午盘股价大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2419651598","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419651598?lang=zh_cn&edition=full","pubTime":"2024-03-14 03:00","pubTimestamp":1710356414,"startTime":"0","endTime":"0","summary":"北京时间2024年03月14日03时00分，Revance Therapeutics, Inc.股票出现波动，股价急速下挫5.01%。Revance Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.32%。其相关个股中，60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Kintara Therapeutics, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大，Kintara Therapeutics, Inc.、Nucana Plc、Paxmedica, Inc.较为活跃，换手率分别为339.02%、112.00%、78.41%，振幅较大的相关个股有180 Life Sciences Corp C/Wts 07/11/2025、Nucana Plc、Nkgen Biotech Inc C/Wts 31/05/2028，振幅分别为82.54%、75.53%、73.20%。Revance Therapeutics, Inc.公司简介：Revance Therapeutics Inc 是一家专注于美容和治疗产品的生物技术公司，包括其神经调节剂产品 DaxibotulinumtoxinA for Injection。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403140300157a4c5ff0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403140300157a4c5ff0&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2418537032","title":"Revance Therapeutics, Inc.盘中异动 早盘股价大跌5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2418537032","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2418537032?lang=zh_cn&edition=full","pubTime":"2024-03-12 21:37","pubTimestamp":1710250667,"startTime":"0","endTime":"0","summary":"北京时间2024年03月12日21时37分，Revance Therapeutics, Inc.股票出现异动，股价快速下挫5.11%。Revance Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.04%。其相关个股中，Regulus Therapeutics Inc.、Tracon Pharmaceuticals, Inc.、Tc Biopharm  Plc涨幅较大，Regulus Therapeutics Inc.、Scisparc Ltd.、Tc Biopharm  Plc较为活跃，换手率分别为219.31%、130.79%、79.22%，振幅较大的相关个股有Regulus Therapeutics Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Tc Biopharm  Plc，振幅分别为57.53%、26.14%、21.64%。Revance Therapeutics, Inc.公司简介：Revance Therapeutics Inc 是一家专注于美容和治疗产品的生物技术公司，包括其神经调节剂产品 DaxibotulinumtoxinA for Injection。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031221374787e7830d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031221374787e7830d&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.revance.com","stockEarnings":[{"period":"1week","weight":0.1252},{"period":"1month","weight":-0.0404},{"period":"3month","weight":-0.2122},{"period":"6month","weight":-0.2848},{"period":"1year","weight":-0.8865},{"period":"ytd","weight":-0.5142}],"compareEarnings":[{"period":"1week","weight":0.0337},{"period":"1month","weight":-0.0029},{"period":"3month","weight":0.0379},{"period":"6month","weight":0.1738},{"period":"1year","weight":0.2586},{"period":"ytd","weight":0.0881}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Revance Therapeutics, Inc.于1999年8月10日成立于特拉华公司，当时名为Essentia Biosystems公司。公司是一家处于专业临床阶段的生物制药公司，专注于开发、制造和商业化用以美容和治疗的异常型肉毒杆菌毒素产品。肉毒杆菌毒素是一种良好的蛋白，目前广泛应用于美容和治疗适应症，在美国和其他国家是一个数十亿美元的市场。目前批准和商用的肉毒杆菌毒素都是注入型的。RT001, 公司的主要候选产品，是a型肉毒毒素局部配方,相对于现有注射肉毒杆菌毒素市场产品，被认为有显著的优势。公司的第二个候选产品RT002，是一种新型注射肉毒杆菌毒素类型的配方，其设计更有针对性，与其他肉毒杆菌毒素注射产品相比，更持久。这些候选产品，结合了公司的净化肉毒杆菌毒素和专有肽输送系统。公司对其两个候选产品，在全球拥有发行权利。","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.017146},{"month":2,"riseRate":0.6,"avgChangeRate":0.034292},{"month":3,"riseRate":0.363636,"avgChangeRate":0.011213},{"month":4,"riseRate":0.454545,"avgChangeRate":-0.023839},{"month":5,"riseRate":0.545455,"avgChangeRate":0.026707},{"month":6,"riseRate":0.7,"avgChangeRate":0.037488},{"month":7,"riseRate":0.2,"avgChangeRate":-0.025716},{"month":8,"riseRate":0.4,"avgChangeRate":-0.015335},{"month":9,"riseRate":0.5,"avgChangeRate":0.012838},{"month":10,"riseRate":0.4,"avgChangeRate":-0.075574},{"month":11,"riseRate":0.3,"avgChangeRate":-0.003095},{"month":12,"riseRate":0.6,"avgChangeRate":0.084189}],"exchange":"NASDAQ","name":"Revance Therapeutics Inc","nameEN":"Revance Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Revance Therapeutics Inc(RVNC)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Revance Therapeutics Inc(RVNC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Revance Therapeutics Inc,RVNC,Revance Therapeutics Inc股票,Revance Therapeutics Inc股票老虎,Revance Therapeutics Inc股票老虎国际,Revance Therapeutics Inc行情,Revance Therapeutics Inc股票行情,Revance Therapeutics Inc股价,Revance Therapeutics Inc股市,Revance Therapeutics Inc股票价格,Revance Therapeutics Inc股票交易,Revance Therapeutics Inc股票购买,Revance Therapeutics Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Revance Therapeutics Inc(RVNC)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Revance Therapeutics Inc(RVNC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况